The Relationship between All-Cause Dementia and Acute Diabetes Complications among American Indian and Alaska Native Peoples
Abstract
:1. Introduction
2. Methods
2.1. Data Source
2.2. Study Population
2.3. Measures
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Arias, E.; Xu, J.; Jim, M.A. Period life tables for the non-Hispanic American Indian and Alaska Native population, 2007–2009. Am. J. Public Health 2014, 104 (Suppl. S3), S312–S319. [Google Scholar] [CrossRef] [PubMed]
- Mayeda, E.R.; Glymour, M.M.; Quesenberry, C.P.; Johnson, J.K.; Perez-Stable, E.J.; Whitmer, R.A. Survival after dementia diagnosis in five racial/ethnic groups. Alzheimer’s Dement. 2017, 13, 761–769. [Google Scholar] [CrossRef]
- Mayeda, E.R.; Glymour, M.M.; Quesenberry, C.P.; Whitmer, R.A. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimer’s Dement. 2016, 12, 216–224. [Google Scholar] [CrossRef] [PubMed]
- Mayeda, E.R.; Karter, A.J.; Huang, E.S.; Moffet, H.H.; Haan, M.N.; Whitmer, R.A. Racial/ethnic differences in dementia risk among older type 2 diabetic patients: The diabetes and aging study. Diabetes Care 2014, 37, 1009–1015. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017; Centers for Disease Control and Prevention, U.S. Department of Health and Human Services: Atlanta, GA, USA, 2017.
- Cobb, N.; Espey, D.; King, J. Health behaviors and risk factors among American Indians and Alaska Natives, 2000–2010. Am. J. Public Health 2014, 104 (Suppl. S3), S481–S489. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020; Centers for Disease Control and Prevention, U.S. Department of Health and Human Services: Atlanta, GA, USA, 2020.
- Doney, A.S.F.; Bonney, W.; Jefferson, E.; Walesby, K.E.; Bittern, R.; Trucco, E.; Connelly, P.; McCrimmon, R.J.; Palmer, C.N.A. Investigating the Relationship between Type 2 Diabetes and Dementia Using Electronic Medical Records in the GoDARTS Bioresource. Diabetes Care 2019, 42, 1973–1980. [Google Scholar] [CrossRef] [PubMed]
- Serrano-Pozo, A.; Growdon, J.H. Is Alzheimer’s Disease Risk Modifiable? J. Alzheimer’s Dis. 2019, 67, 795–819. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.X.; Tian, Y.; Wang, Z.T.; Ma, Y.H.; Tan, L.; Yu, J.T. The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention. J. Prev. Alzheimer’s Dis. 2021, 8, 313–321. [Google Scholar] [CrossRef] [PubMed]
- Chin, S.O.; Rhee, S.Y.; Chon, S.; Baik, S.H.; Park, Y.; Nam, M.S.; Lee, K.W.; Chun, K.H.; Woo, J.T.; Kim, Y.S. Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: An analysis based on the Korea National Diabetes Program Cohort. Diabetes Res. Clin. Pract. 2016, 122, 54–61. [Google Scholar] [CrossRef]
- Cukierman-Yaffe, T.; Gerstein, H.C.; Williamson, J.D.; Lazar, R.M.; Lovato, L.; Miller, M.E.; Coker, L.H.; Murray, A.; Sullivan, M.D.; Marcovina, S.M.; et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: The action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009, 32, 221–226. [Google Scholar] [CrossRef]
- Feil, D.G.; Rajan, M.; Soroka, O.; Tseng, C.L.; Miller, D.R.; Pogach, L.M. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: Implications for practice and policy. J. Am. Geriatr. Soc. 2011, 59, 2263–2272. [Google Scholar] [CrossRef] [PubMed]
- Lee, A.K.; Rawlings, A.M.; Lee, C.J.; Gross, A.L.; Huang, E.S.; Sharrett, A.R.; Coresh, J.; Selvin, E. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: The Atherosclerosis Risk in Communities (ARIC) cohort study. Diabetologia 2018, 61, 1956–1965. [Google Scholar] [CrossRef] [PubMed]
- Lin, C.H.; Sheu, W.H. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J. Intern. Med. 2013, 273, 102–110. [Google Scholar] [CrossRef] [PubMed]
- Mehta, H.B.; Mehta, V.; Goodwin, J.S. Association of Hypoglycemia with Subsequent Dementia in Older Patients with Type 2 Diabetes Mellitus. J. Gerontol. A Biol. Sci. Med. Sci. 2017, 72, 1110–1116. [Google Scholar]
- Prinz, N.; Stingl, J.; Dapp, A.; Denkinger, M.D.; Fasching, P.; Jehle, P.M.; Merger, S.; Mühldorfer, S.; Pieper, U.; Schuler, A.; et al. High rate of hypoglycemia in 6770 type 2 diabetes patients with comorbid dementia: A multicenter cohort study on 215,932 patients from the German/Austrian diabetes registry. Diabetes Res. Clin. Pract. 2016, 112, 73–81. [Google Scholar] [CrossRef]
- Punthakee, Z.; Miller, M.E.; Launer, L.J.; Williamson, J.D.; Lazar, R.M.; Cukierman-Yaffee, T.; Seaquist, E.R.; Ismail-Beigi, F.; Sullivan, M.D.; Lovato, L.C.; et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012, 35, 787–793. [Google Scholar] [CrossRef] [PubMed]
- Whitmer, R.A.; Karter, A.J.; Yaffe, K.; Quesenberry, C.P., Jr.; Selby, J.V. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301, 1565–1572. [Google Scholar] [CrossRef]
- Yaffe, K.; Falvey, C.M.; Hamilton, N.; Harris, T.B.; Simonsick, E.M.; Strotmeyer, E.S.; Shorr, R.I.; Metti, A.; Schwartz, A.V. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern. Med. 2013, 173, 1300–1306. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.L.; Weng, S.F.; Yang, C.Y.; Wang, J.J.; Tien, K.J. Diabetic ketoacidosis further increases risk of Alzheimer’s disease in patients with type 2 diabetes. Diabetes Res. Clin. Pract. 2019, 147, 55–61. [Google Scholar] [CrossRef]
- Lacy, M.E.; Gilsanz, P.; Eng, C.W.; Beeri, M.S.; Karter, A.J.; Whitmer, R.A. Recurrent diabetic ketoacidosis and cognitive function among older adults with type 1 diabetes: Findings from the Study of Longevity in Diabetes. BMJ Open Diabetes Res. Care 2020, 8, e001173. [Google Scholar] [CrossRef]
- Dixon, M.; Roubideaux, Y. (Eds.) Promises to Keep: Public Health Policy for American Indians and Alaska Natives in the 21st Centurty; American Public Health Association: Washington, DC, USA, 2001. [Google Scholar]
- U.S. Department of Health and Human Services, Indian Health Service. IHS Year 2015 Profile Based on 2000–2014 Data—Numbers Are Approximate. 26 April 2015. Available online: https://web.pdx.edu/~nwallace/AHP/IHS.pdf (accessed on 3 October 2023).
- U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services. National Health Expenditures 2014 Highlights Series National Health Expenditure Data 2015. Available online: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/highlights.pdf (accessed on 3 October 2023).
- National Congress of American Indians, Policy Research Center. Research Policy Update—A First Look at the 2020 Census American Indian/Alaska Native Redistricting Data. 2021. Available online: https://archive.ncai.org/policy-research-center/research-data/prc-publications/Overview_of_2020_AIAN_Redistricting_Data_FINAL_8_13_2021.pdf (accessed on 3 October 2023).
- Indian Health Service. IHS Year 2021 Profile. Based on 2015-2020 data. U.S. Department of Health and Human Services. 2021. Available online: https://www.ihs.gov/newsroom/factsheets/ihsprofile/ (accessed on 3 October 2023).
- O’Connell, J.; Guh, S.; Ouellet, J.; Li, Y.; Rockell, J.; Croy, C.; Gutilla, M. ARRA ACTION: Comparative Effectiveness of Health Care Delivery Systems for American Indians and Alaska Natives Using Enhanced Data Infrastructure: Final Report; Agency for Healthcare Research and Quality: Rockville, MD, USA, 2014.
- Espey, D.K.; Jim, M.A.; Cobb, N.; Bartholomew, M.; Becker, T.; Haverkamp, D.; Plescia, M. Leading causes of death and all-cause mortality in American Indians and Alaska Natives. Am. J. Public Health 2014, 104 (Suppl. S3), S303–S311. [Google Scholar] [CrossRef] [PubMed]
- Nichols, G.A.; Schroeder, E.B.; Karter, A.J.; Gregg, E.W.; Desai, J.; Lawrence, J.M.; O’Connor, P.J.; Xu, S.; Newton, K.M.; Raebel, M.A.; et al. Trends in diabetes incidence among 7 million insured adults, 2006-2011: The SUPREME-DM project. Am. J. Epidemiol. 2015, 181, 32–39. [Google Scholar] [CrossRef] [PubMed]
- Lipska, K.J.; Ross, J.S.; Wang, Y.; Inzucchi, S.E.; Minges, K.; Karter, A.J.; Huang, E.S.; Desai, M.M.; Gill, T.M.; Krumholz, H.M. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern. Med. 2014, 174, 1116–1124. [Google Scholar] [CrossRef] [PubMed]
- Geller, A.I.; Shehab, N.; Lovegrove, M.C.; Kegler, S.R.; Weidenbach, K.N.; Ryan, G.J.; Budnitz, D.S. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern. Med. 2014, 174, 678–686. [Google Scholar] [CrossRef] [PubMed]
- Desai, D.; Mehta, D.; Mathias, P.; Menon, G.; Schubart, U.K. Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis. Diabetes Care 2018, 41, 1631–1638. [Google Scholar] [CrossRef] [PubMed]
- Goodman, R.A.; Lochner, K.A.; Thambisetty, M.; Wingo, T.S.; Posner, S.F.; Ling, S.M. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011–2013. Alzheimer’s Dement. 2017, 13, 28–37. [Google Scholar] [CrossRef] [PubMed]
- Verisk Health, Inc. Sightlines™ DxCG Risk Solutions, Version 4.0.1; Verisk Health, Inc.: Jersey City, NJ, USA, 2011. [Google Scholar]
- Kluwer, W. Medi-Span® Generic Product Identifier (GPI). 2018. Available online: http://www.wolterskluwercdi.com/drug-data/gpi/ (accessed on 25 January 2022).
- Haroon, N.N.; Austin, P.C.; Shah, B.R.; Wu, J.; Gill, S.S.; Booth, G.L. Risk of dementia in seniors with newly diagnosed diabetes: A population-based study. Diabetes Care 2015, 38, 1868–1875. [Google Scholar] [CrossRef]
- de Galan, B.E.; Zoungas, S.; Chalmers, J.; Anderson, C.; Dufouil, C.; Pillai, A.; Cooper, M.; Grobbee, D.E.; Hackett, M.; Hamet, P.; et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009, 52, 2328–2336. [Google Scholar] [CrossRef]
- Abdelhafiz, A.H.; McNicholas, E.; Sinclair, A.J. Hypoglycemia, frailty and dementia in older people with diabetes: Reciprocal relations and clinical implications. J. Diabetes Complicat. 2016, 30, 1548–1554. [Google Scholar] [CrossRef]
- Hambling, C.E.; Seidu, S.I.; Davies, M.J.; Khunti, K. Older people with Type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies. Diabet. Med. 2017, 34, 1219–1227. [Google Scholar] [CrossRef]
- Arlt, S.; Lindner, R.; Rösler, A.; von Renteln-Kruse, W. Adherence to medication in patients with dementia: Predictors and strategies for improvement. Drugs Aging 2008, 25, 1033–1047. [Google Scholar] [CrossRef] [PubMed]
- Smith, D.; Lovell, J.; Weller, C.; Kennedy, B.; Winbolt, M.; Young, C.; Ibrahim, J. A systematic review of medication non-adherence in persons with dementia or cognitive impairment. PLoS ONE 2017, 12, e0170651. [Google Scholar] [CrossRef] [PubMed]
- American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020, 43, S66–S76. [Google Scholar] [CrossRef] [PubMed]
- American Diabetes Association. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020, 43, S7–S13. [Google Scholar] [CrossRef]
- U.S. Government Accountability Office, Indian Health Service. Agency faces ongoing challenges filling provider vacancies. In Report to Congressional Requesters; U.S. Government Accountability Office: Washington, DC, USA, 2018. [Google Scholar]
- Jervis, L.L.; Manson, S.M. American Indians/Alaska Natives and dementia. Alzheimer Dis. Assoc. Disord. 2002, 16, S89–S95. [Google Scholar] [CrossRef]
All | Without Dementia | With Dementia | |
---|---|---|---|
Total n | 29,337 | 28,494 | 843 |
Age (years) | 61.7 ± 10.5 | 61.2 ± 10.2 | 76.6 ± 11.1 |
Age categories (%) | |||
45–64 | 65.4 | 66.9 | 16.5 |
65–74 | 22.1 | 22.2 | 20.5 |
75+ | 12.5 | 11.0 | 63.0 |
Female (%) | 56.1 | 56.1 | 57.3 |
Health coverage (%) | |||
Medicare | 42.6 | 41.3 | 85.3 |
Medicaid | 12.3 | 12.0 | 22.1 |
Private | 14.3 | 14.5 | 7.0 |
Comorbidities (%) | |||
CVD | 38.7 | 37.8 | 70.2 |
Cancer | 6.1 | 6.0 | 10.3 |
Liver disease | 10.7 | 10.6 | 15.1 |
Hypertension | 86.7 | 86.5 | 94.0 |
Depression | 24.9 | 24.6 | 36.9 |
Mental illness other than depression c | 23.9 | 23.4 | 41.8 |
Alcohols and drug use disorder | 11.8 | 11.6 | 17.3 |
Tobacco use disorder | 16.5 | 16.6 | 10.8 |
Number of comorbidities | 2.2 ± 1.3 | 2.2 ± 1.3 | 3.0 ± 1.3 |
Medications (n = 24,964) (%) d | |||
Dyslipidemia medication e | 55.4 | 55.6 | 48.1 |
Diabetes medication | |||
Insulin only | 10.0 | 9.8 | 19.7 |
Oral only | 40.2 | 40.6 | 26.4 |
Insulin and oral combined | 19.8 | 19.9 | 16.4 |
No diabetes medication | 30.0 | 29.8 | 37.5 |
Hypertension medication f | 74.8 | 74.8 | 74.5 |
Clinical measurements | |||
LDL (mg/dL) (n = 17,231) g | 92.5 ± 32.4 | 92.7 ± 32.4 | 83.8 ± 31.3 |
A1c (%) (n = 19,891) | 7.9 ± 2.0 | 7.9 ± 2.0 | 7.4 ± 1.7 |
Systolic blood pressure (mmHg) (n = 22,730) | 131.9 ± 15.0 | 131.9 ± 14.9 | 129.8 ± 16.8 |
All | Without Any Complication | Only Hypoglycemia | Only Hyperglycemia | Both Complications | |
---|---|---|---|---|---|
Total n | 29,337 | 26,859 | 1043 | 1199 | 236 |
Age (years) | 61.7 ± 10.5 | 61.6 ± 10.5 | 65.7 ± 11.0 | 58.4 ± 9.3 | 62.1 ± 11.6 |
Age categories (%) | |||||
45–64 | 65.4 | 65.5 | 49.4 | 77.8 | 65.7 |
65–74 | 22.1 | 22.2 | 27.8 | 15.8 | 16.5 |
75+ | 12.5 | 12.3 | 22.8 | 6.4 | 17.8 |
Female (%) | 56.1 | 56.1 | 58.3 | 54.1 | 56.4 |
Health coverage (%) | |||||
Medicare | 42.6 | 42.0 | 62.0 | 36.2 | 52.5 |
Medicaid | 12.3 | 11.8 | 19.1 | 17.2 | 18.6 |
Private | 14.3 | 14.6 | 10.3 | 12.0 | 11.0 |
Comorbidities (%) | |||||
CVD | 38.7 | 36.8 | 68.6 | 50.0 | 68.6 |
Cancer | 6.1 | 6.0 | 8.4 | 5.9 | 6.4 |
Liver disease | 10.7 | 10.1 | 16.4 | 17.0 | 18.6 |
Hypertension | 86.7 | 86.2 | 94.6 | 89.7 | 92.8 |
Depression | 24.9 | 24.3 | 29.9 | 31.7 | 40.7 |
Mental illness other than depression c | 23.9 | 23.3 | 30.6 | 29.4 | 36.4 |
Alcohols and drug use disorder | 11.8 | 10.9 | 19.2 | 22.8 | 30.1 |
Tobacco use disorder | 16.5 | 16.2 | 14.7 | 22.3 | 21.2 |
Dementia | 2.9 | 2.5 | 9.9 | 2.6 | 11.4 |
Number of comorbidities | 2.2 ± 1.3 | 2.1 ± 1.3 | 2.8 ± 1.3 | 2.7 ± 1.4 | 3.1 ± 1.4 |
Medications (n = 24,964) (%) d | |||||
Dyslipidemia medication e | 55.4 | 54.8 | 63.2 | 61.9 | 58.3 |
Diabetes medication | |||||
Insulin only | 10.0 | 8.4 | 24.4 | 25.3 | 41.7 |
Oral only | 40.2 | 42.0 | 27.5 | 18.8 | 8.8 |
Insulin and oral combined | 19.8 | 18.2 | 30.7 | 41.9 | 36.1 |
No diabetes medication | 30.0 | 31.4 | 17.5 | 14.1 | 13.4 |
Hypertension medication f | 74.8 | 73.9 | 85.7 | 82.2 | 82.4 |
Clinical measurements | |||||
LDL (mg/dL) (n = 17,231) g | 92.5 ± 32.4 | 92.8 ± 32.3 | 84.9 ± 30.8 | 94.6 ± 35.2 | 87.6 ± 36.3 |
A1c (%) (n = 19,891) | 7.9 ± 2.0 | 7.8 ± 1.9 | 8.2 ± 2.1 | 9.4 ± 2.3 | 9.0 ± 2.0 |
Systolic blood pressure (mmHg) (n = 22,730) | 131.9 ± 15.0 | 131.9 ± 14.9 | 131.6 ± 16.6 | 131.9 ± 15.6 | 131.7 ± 16.3 |
Diabetic Complications | Total | Without Dementia | With Dementia | p-Value |
---|---|---|---|---|
Overall | n = 29,337 | n = 28,494 | n = 843 | |
Hypoglycemia | 1279 (4.4%) | 1149 (4.0%) | 130 (15.4%) | <0.0001 |
Hyperglycemia | 1435 (4.9%) | 1377 (4.8%) | 58 (6.9%) | 0.0066 |
Diabetic Ketoacidosis | 268 (0.9%) | 257 (0.9%) | 11 (1.3%) | 0.226 |
Female | n = 16,454 | n = 15,971 | n = 483 | |
Hypoglycemia | 741 (4.5%) | 662 (4.2%) | 79 (16.4%) | <0.0001 |
Hyperglycemia | 782 (4.8%) | 745 (4.7%) | 37 (7.7%) | 0.0023 |
Diabetic Ketoacidosis | 118 (0.7%) | 110 (0.7%) | 8 (1.7%) | 0.0230 |
Male | n = 12,883 | n = 12,523 | n = 360 | |
Hypoglycemia | 538 (4.2%) | 487 (3.9%) | 51 (14.2%) | <0.0001 |
Hyperglycemia | 653 (5.1%) | 632 (5.1%) | 21 (5.8%) | 0.502 |
Diabetic Ketoacidosis | 150 (1.2%) | 147 (1.2%) | 3 (0.8%) | 0.802 |
45–64 | n = 19,196 | n = 19,057 | n = 139 | |
Hypoglycemia | 670 (3.5%) | 650 (3.4%) | 20 (14.4%) | <0.0001 |
Hyperglycemia | 1088 (5.7%) | 1071 (5.6%) | 17 (12.2%) | 0.0008 |
Diabetic Ketoacidosis | 222 (1.2%) | 219 (1.2%) | 3 (2.2%) | 0.218 |
65–74 | n = 6486 | n = 6313 | n = 173 | |
Hypoglycemia | 329 (5.1%) | 300 (4.8%) | 29 (16.8%) | <0.0001 |
Hyperglycemia | 228 (3.5%) | 210 (3.3%) | 18 (10.4%) | <0.0001 |
Diabetic Ketoacidosis | 31 (0.5%) | 26 (0.4%) | 5 (2.9%) | 0.0012 |
75 or more | n = 3655 | n = 3124 | n = 531 | |
Hypoglycemia | 280 (7.7%) | 199 (6.4%) | 81 (15.3%) | <0.0001 |
Hyperglycemia | 119 (3.3%) | 96 (3.1%) | 23 (4.3%) | 0.131 |
Diabetic Ketoacidosis | 15 (0.4%) | 12 (0.4%) | 3 (0.6%) | 0.470 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Niu, X.; Chang, J.; Corrada, M.M.; Bullock, A.; Winchester, B.; Manson, S.M.; O’Connell, J.; Jiang, L. The Relationship between All-Cause Dementia and Acute Diabetes Complications among American Indian and Alaska Native Peoples. Int. J. Environ. Res. Public Health 2024, 21, 496. https://doi.org/10.3390/ijerph21040496
Niu X, Chang J, Corrada MM, Bullock A, Winchester B, Manson SM, O’Connell J, Jiang L. The Relationship between All-Cause Dementia and Acute Diabetes Complications among American Indian and Alaska Native Peoples. International Journal of Environmental Research and Public Health. 2024; 21(4):496. https://doi.org/10.3390/ijerph21040496
Chicago/Turabian StyleNiu, Xiaoyi, Jenny Chang, Maria M. Corrada, Ann Bullock, Blythe Winchester, Spero M. Manson, Joan O’Connell, and Luohua Jiang. 2024. "The Relationship between All-Cause Dementia and Acute Diabetes Complications among American Indian and Alaska Native Peoples" International Journal of Environmental Research and Public Health 21, no. 4: 496. https://doi.org/10.3390/ijerph21040496